These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27583669)

  • 21. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
    Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
    Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The airway microbiota in early cystic fibrosis lung disease.
    Frayman KB; Armstrong DS; Grimwood K; Ranganathan SC
    Pediatr Pulmonol; 2017 Nov; 52(11):1384-1404. PubMed ID: 28815937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the type of chronic pulmonary infection a determinant of lung function outcomes in adult patients with cystic fibrosis?
    Lopes AJ; Mafort TT; de Sá Ferreira A; Santos de Castro MC; Cássia de Firmida M; de Andrade Marques E
    Monaldi Arch Chest Dis; 2012; 77(3-4):122-8. PubMed ID: 23461248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
    Cribbs SK; Beck JM
    Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
    Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
    J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis could be one of the anti-cheating mechanisms for Pseudomonas aeruginosa society.
    Huang Z; Jiang Y; Liang J
    Med Hypotheses; 2011 Feb; 76(2):166-8. PubMed ID: 20934258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host-pathogen interplay in the respiratory environment of cystic fibrosis.
    Yonker LM; Cigana C; Hurley BP; Bragonzi A
    J Cyst Fibros; 2015 Jul; 14(4):431-439. PubMed ID: 25800687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
    Sherrard LJ; Tunney MM; Elborn JS
    Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing?
    Whelan FJ; Surette MG
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S207-11. PubMed ID: 26595741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information.
    Cobián Güemes AG; Lim YW; Quinn RA; Conrad DJ; Benler S; Maughan H; Edwards R; Brettin T; Cantú VA; Cuevas D; Hamidi R; Dorrestein P; Rohwer F
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
    Amin R; Lam M; Dupuis A; Ratjen F
    Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Microbiome in Cystic Fibrosis.
    Huang YJ; LiPuma JJ
    Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anaerobes in cystic fibrosis patients' airways.
    Lamoureux C; Guilloux CA; Beauruelle C; Jolivet-Gougeon A; Héry-Arnaud G
    Crit Rev Microbiol; 2019 Feb; 45(1):103-117. PubMed ID: 30663924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The airway microbiome in cystic fibrosis and implications for treatment.
    Zemanick ET; Sagel SD; Harris JK
    Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.